Cytori: A Must Own Biotech

On March 11, 2011, Cytori reported financial results for the fourth quarter and full year ended December 31, 2010. Total revenues in the quarter were $2.5 million, above our expectations for total revenues of $2.0 million. Upside came from strong consumable shipments and reorders, as well as strong initial update for PureGraft in only its second quarter on the market. Installed Base Q4 2010 Comps Reported Zacks Est. Q3 2010 Q4 2009 Revenue Systems (cumulative) 149 149 135 101 Consumables Shipped 437 275 221 337 Consumable Re-Orders 350 193 162 258 % Re-Orders 80% 70% 73% 77% Utilization Rate...

Source:
http://article.wn.com/view/2011/04/14/Cytori_A_Must_Own_Biotech/

world today news www.world news world news latest updated news channel 12 news long island